Semaglutide reduces the risk of heart attack, stroke, and other major cardiac events. | Drug Discovery And Development ...

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and ...

Semaglutide appears to be protective against heart attacks and other cardiac events regardless of weight loss, research has ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much ...

Even when weight doesn’t drop much, the obesity-medication semaglutide still offers major heart-protection, research shows.

Semaglutide lowered the risk of major adverse cardiovascular events across all body weight and waist circumference levels in ...

Academics set out to examine the additional benefits of semaglutide, which is the main ingredient of Wegovy and also type 2 ...

More work needs to be done to tease out the mechanisms by which GLP-1 RAs lower the risk of MACE, researchers say.

The cardiovascular benefits of weight loss drug semaglutide (Ozempic, Wegovy) occur regardless of how much weight a person loses or their starting body weight, new analysis suggests.1 Study authors ...